CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
Jan. 24, 2024—The company iSpecimen, an online marketplace that connects life science researchers seeking human biospecimens for medical research with health care organizations that have such specimens, announced it has entered into a pilot program agreement with TriMetis Life Sciences. By combining iSpecimen’s network of suppliers and researchers with TriMetis’ AI-powered, automated digital pathology solutions, the partnership will work to address industry challenges, reduce the risk of errors associated with manual processes, and revolutionize tissue assessment for preclinical research.
“This pilot program exemplifies the fusion of two online portals, leveraging cutting-edge technological tools to both enhance customer service and elevate industry standards,” Tracy Curley, CEO of iSpecimen, said in a joint statement. “By incorporating AI readings and images, our goal is to enhance the standardization of tissue-based oncology samples on the iSpecimen Marketplace, contributing to a transformative shift in the quality assessments of tissue samples.”